Redundant text below John Friend Mahoney was an American physician best known as a pioneer in the treatment of syphilis with penicillin. He won the 1946 Lasker Award.
From 1917 he worked as an assistant surgeon in the US forces in Europe during World War I. After returning in 1919, he served in the United States Public Health Service on various quarantine stations and marine hospitals, including Ellis Island. In this context, it was from 1925 to 1929 that he was sent to Europe. While in England, Ireland, and Germany, Mahoney studied syphilis treatment. Since 1929 Mahoney was Director of the Venereal Disease Research Laboratory of the Food and Drug Administration. The laboratory improved serological tests for syphilis and demonstrated, with the advent of sulfonamide treatment in the United States in the 1930s, its efficacy in gonorrhea. He was also Medical Director of the Marine Hospital in Staten Island. Mahoney was made aware of the possibilities of penicillin treatment by a paper of Wallace Herrell and colleagues from the Mayo Clinic. Particular attention was on the treatment of gonorrhea patients where the pathogen was resistant to sulfonamides. Mahoney could confirm this and also began to test penicillin for syphilis, first in vitro without success, then in rabbits. Dr. John F Mahoney lead the Terre Haute Prison experiments and supervised Dr. Cutler in the Guatemala Syphilis Experiment. By 1929, Dr. Mahoney worked as the director of the Venereal Disease Research Lab in Staten island, where the Terre Haute experiments began in 1943, this is also where Cutler first assisted him. After stopping the Terre Haute experiments for lack of accurate infection of subjects with gonorrhea, Dr. Mahoney moved on to study the effects of penicillin on syphilis. His research found huge success for penicillin treatments and the US army embraced it in STD prescription. Although this seemed prosperous, Mahoney and his collaborators questioned the long term effectiveness of eliminating the disease all together in individuals. Mahoney, Cutler, and other researchers, felt that a smaller, more controlled group of individuals to study would be more helpful in finding this cure. This led to the use of citizens in Guatemala as subjects. Once this had been successful he began clinical trials. He presented at a meeting of the American Public Health Association in New York in October 1943 the first results in four patients in the early stages of the disease. Time reported the findings. With Mahoney's involvement, the Committee on Medical Research began an extensive clinical trial with over 1400 patients in different hospitals. Mahoney led the study at the Staten Island Marine Hospital. In June 1944 penicillin was introduced as a standard treatment for syphilis in the United States Army. In 1946 Mahoney was one of the first winners of the Lasker Award. In 1948 he was Chairman of the World Health Organization Expert Committee on Venereal Diseases at its first meeting in Geneva. In December 1949 he retired from the Public Health Service. In 1950 he was appointed Commissioner of the New York City Department of Health, serving until 1953. Dr. John F Mahoney lead the Terre Haute Prison experiments and supervised Dr. Cutler in the Guatemala Syphilis Experiment. Mahoney graduated from medical school in 1914 and by 1918 was titled Assistant Surgeon at the United States Public Health Service. By 1929, Dr. Mahoney worked as the director of the Venereal Disease Research Lab is Staten island, where the Terre Haute experiments began in 1943, this is also where Cutler first assisted him. After stopping the Terre Haute experiments for lack of accurate infection of subjects with gonorrhea, Dr. Mahoney moved on to study the effects of penicillin on syphilis. His research found huge success for penicillin treatments and the US army embraced it in STD prescription. Although this seemed prosperous, Mahoney and his collaborators questioned the long term effectiveness of eliminating the disease all together in individuals. Mahoney, Cutler, and other researchers, felt that a smaller, more controlled group of individuals to study would be more helpful in finding this cure. This led to the use of citizens in Guatemala as subjects. Until his death, he was director of the laboratories of the municipal health authorities of New York.
